Assignee
XUANZHU PHARMA CO LTD
CN·18 granted patents·2 pending applications·20 citations·filing 2012–2017
Top patents by PatentIndex Score
20 records- 0183US9796701B2Kinase inhibitor and use thereofXUANZHU PHARMA CO LTD·Filed 2014·Granted Oct 24, 2017·3 cites·22 claims
- 0283US9284315B2Three-ring PI3K and/or mTOR inhibitorXUANZHU PHARMA CO LTD·Filed 2012·Granted Mar 15, 2016·7 cites·8 claims
- 0378US9956222B2Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereofXUANZHU PHARMA CO LTD·Filed 2017·Granted May 1, 2018·2 cites·21 claims
- 0477US9315438B2Optically pure benzyl-4-chlorophenyl-C-glucoside derivativeXUANZHU PHARMA CO LTD·Filed 2014·Granted Apr 19, 2016·1 cites·21 claims
- 0575US9487545B2Fused ring-containing oxazolidinones antibioticsXUANZHU PHARMA CO LTD·Filed 2012·Granted Nov 8, 2016·2 cites·10 claims
- 0671US9359371B2Bicyclic substituted pyrimidine compoundsXUANZHU PHARMA CO LTD·Filed 2013·Granted Jun 7, 2016·2 cites·16 claims
- 0768US10689359B2Crystals of quinazoline derivative and preparation method thereforXUANZHU PHARMA CO LTD·Filed 2016·Granted Jun 23, 2020·1 cites·20 claims
- 0867US10011592B2Polycyclic inhibitor of anaplastic lymphoma kinaseXUANZHU PHARMA CO LTD·Filed 2015·Granted Jul 3, 2018·1 cites·15 claims
- 0966US10300058B2Tyrosine kinase inhibitor and uses thereofXUANZHU PHARMA CO LTD·Filed 2015·Granted May 28, 2019·1 cites·16 claims
- 1060US9914688B2Optically pure benzyl-4-chlorophenyl-C-glucoside derivativeXUANZHU PHARMA CO LTD·Filed 2016·Granted Mar 13, 2018·0 cites·2 claims
- 1151US10633364B2Crystals of quinazoline derivative and preparation method thereforXUANZHU PHARMA CO LTD·Filed 2016·Granted Apr 28, 2020·0 cites·20 claims
- 1248US9181244B1Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitorsXUANZHU PHARMA CO LTD·Filed 2014·Granted Nov 10, 2015·0 cites·15 claims
- 1348US2017304305A1Quinazoline derivatives substituted by aniline, preparation method and use thereofXUANZHU PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1447US11111234B2Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereofXUANZHU PHARMA CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·15 claims
- 1547US10507209B2Quinazoline derivatives substituted by aniline, preparation method and use thereofXUANZHU PHARMA CO LTD·Filed 2017·Granted Dec 17, 2019·0 cites·3 claims
- 1647US9359344B2Biaryl heterocycle substituted oxazolidinone antibacterial agentsXUANZHU PHARMA CO LTD·Filed 2012·Granted Jun 7, 2016·0 cites·9 claims
- 1742US10167283B2β-lactamase inhibitors and uses thereofXUANZHU PHARMA CO LTD·Filed 2016·Granted Jan 1, 2019·0 cites·24 claims
- 1842US9365572B2PI3K and/or mTOR inhibitorXUANZHU PHARMA CO LTD·Filed 2013·Granted Jun 14, 2016·0 cites·9 claims
- 1939US9527876B2Prodrugs of bicyclic substituted pyrimidine type PDE-5 inhibitorsXUANZHU PHARMA CO LTD·Filed 2014·Granted Dec 27, 2016·0 cites·17 claims
- 2034US2016176892A1Benzimidazole derivatives and their pharmaceutical compositions and usesXUANZHU PHARMA CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XUANZHU PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →